Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infant developmental safety after maternal tenofovir disoproxil fumarate use in mid-to-late pregnancy for prevention of hepatitis B mother-to-child transmission
ChiCTR1900025111Phase 4Recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir disoproxil fumarate in hepatitis B (HBV) (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoint: Infant bone density. Started Aug 2019; status: recruiting.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on ChiCTR1900025111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025111.